![](/images/graphics-bg.png)
Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”
Author
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-01-29
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium” [1], there were errors in the description of Figure 1 and Table 1.
The last sentence of Figure 1 should be updated from “LABA, long-acting β2-agonist” to “IL, interleukin; LABA, long-acting β2-agonist; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroid; SABA, short-acting β2-agonist.” In addition, the last sentence of Table 1 should be updated from “LABA, long-acting β2-agonist; N/A, not applicable; NR, not reported; NS, not significant" to “ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; N/A, not applicable; NR, not reported.”
American Psychological Association (APA)
Hamelmann, E.. 2019. Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”. BioMed Research International،Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1127938
Modern Language Association (MLA)
Hamelmann, E.. Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”. BioMed Research International No. 2019 (2019), pp.1-1.
https://search.emarefa.net/detail/BIM-1127938
American Medical Association (AMA)
Hamelmann, E.. Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1127938
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1127938